← Back to home

Hematologic Malignancies I — Vignettes 1

Clinical Medicine and Surgery I · Exam 8 · Lecture 49
30 questions

Before you begin

Count the blasts first (marrow blast percentage decides acute leukemia against myelodysplasia, and the phase of chronic myelogenous leukemia), then the cell line and the hallmark finding, then the patient's fitness and comorbidities before choosing a treatment. Every laboratory value comes with its normal range.

Count the blastsGrade the fitnessStage the CMLRead the milestonePick the treatmentComorbiditiesAcross the lifespan

Answers reveal only after you choose. Your score and a breakdown by objective appear at the end, with a review of everything you missed.

View
Length